Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3316603 | Pancreatology | 2014 | 5 Pages |
Abstract
Overall, our older patients did not have an inferior outcome compared to the reported trial populations that included younger patients. Thus, palliative chemotherapy should be considered independently from chronological age, but the performance status should be carefully noticed. Second-line therapy should be considered for patients in good performance status after first progression.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Anne Katrin Berger, Ulrich Abel, Christine Komander, Sabine Harig, Dirk Jäger, Christoph Springfeld,